当前位置:首页 > 文献互助 > 互助详情

Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder复制

用户tyBLOT48grSw 1小时前 13 10 待确认 帖子自动结束时间: 2026-06-16 15:58:19

1. 请及时下载文件确认是否正确, 系统将在 2026-06-18 16:16:13 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

AJ Cutler, GW Mattingly, SG Kornstein…
J Clin …, 2024
psychiatrist.com
Objective: Zuranolone is a positive allosteric modulator of both synaptic and extrasynaptic γ-aminobutyric acid (GABA) type A receptors and a neuroactive steroid approved in the United States as an oral, once-daily, 14-day treatment course for adults with postpartum depression and under investigation for adults with major depressive disorder (MDD). Interim results from the open-label, longitudinal, phase 3 SHORELINE Study (NCT03864614) that evaluated the longterm safety and efficacy of zuranolone in adults with MDD are reported. Methods: This …

互助时间线

2026-06-11 16:16:13 [上传文件]

jodie0105上传了文件(pdf 2.26 MB), 求助状态变成 待确认

2026-06-11 15:58:19 [发起求助]

最新发布的求助